| Primary information |
|---|
| ID | antitb_1323, |
| Name | 21464254 |
| N-Terminal modification | 1-Nssb |
| C-Terminal Modification | H-(NLys-Nssb-Nssb)4-NH2 |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | Nlys = N-(4-aminobutyl)glycine, Nssb = (S)-N-(sec-butyl)glycine |
| Chirality | Linear |
| Nature | 12 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
| Cell Line | MIC = >100 μM |
| Inhibition Concentration | In vitro |
| Sequence | 2011 |
| Cytotoxicity | Raw 264.7 and J774 mouse macrophage |
| In vivo Model | NA |
| Lethal Dose | Non toxic |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |
| Primary information |
|---|
| ID | antitb_1329, |
| Name | 21464254 |
| N-Terminal modification | 1-Nssb |
| C-Terminal Modification | H-(NLys-Nssb-Nssb)4-NH2 |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | Nlys = N-(4-aminobutyl)glycine, Nssb = (S)-N-(sec-butyl)glycine |
| Chirality | Linear |
| Nature | 12 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium bovis |
| In Vitro/ In vivo | Mycobacterium bovis BCG |
| Cell Line | MIC = >100 μM |
| Inhibition Concentration | In vitro |
| Sequence | 2011 |
| Cytotoxicity | Raw 264.7 and J774 mouse macrophage |
| In vivo Model | NA |
| Lethal Dose | Non toxic |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |